Logo image of AXIL

AXIL BRANDS INC (AXIL) Stock Fundamental Analysis

NYSEARCA:AXIL - NYSE Arca - US76151R2067 - Common Stock - Currency: USD

4.94  -0.06 (-1.2%)

Fundamental Rating

5

Taking everything into account, AXIL scores 5 out of 10 in our fundamental rating. AXIL was compared to 35 industry peers in the Personal Care Products industry. While AXIL has a great health rating, its profitability is only average at the moment. AXIL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

AXIL had positive earnings in the past year.
In the past year AXIL had a positive cash flow from operations.
In multiple years AXIL reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: AXIL reported negative operating cash flow in multiple years.
AXIL Yearly Net Income VS EBIT VS OCF VS FCFAXIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

Looking at the Return On Assets, with a value of 19.15%, AXIL belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
AXIL has a better Return On Equity (25.68%) than 88.57% of its industry peers.
AXIL's Return On Invested Capital of 10.72% is fine compared to the rest of the industry. AXIL outperforms 71.43% of its industry peers.
Industry RankSector Rank
ROA 19.15%
ROE 25.68%
ROIC 10.72%
ROA(3y)9.28%
ROA(5y)-2.18%
ROE(3y)-9.42%
ROE(5y)-29.73%
ROIC(3y)N/A
ROIC(5y)N/A
AXIL Yearly ROA, ROE, ROICAXIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

AXIL has a Profit Margin of 9.18%. This is amongst the best in the industry. AXIL outperforms 82.86% of its industry peers.
The Operating Margin of AXIL (4.76%) is comparable to the rest of the industry.
AXIL has a Gross Margin of 71.40%. This is in the better half of the industry: AXIL outperforms 71.43% of its industry peers.
In the last couple of years the Gross Margin of AXIL has grown nicely.
Industry RankSector Rank
OM 4.76%
PM (TTM) 9.18%
GM 71.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.09%
GM growth 5Y10.63%
AXIL Yearly Profit, Operating, Gross MarginsAXIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AXIL is creating some value.
The number of shares outstanding for AXIL has been increased compared to 1 year ago.
The number of shares outstanding for AXIL has been increased compared to 5 years ago.
Compared to 1 year ago, AXIL has an improved debt to assets ratio.
AXIL Yearly Shares OutstandingAXIL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
AXIL Yearly Total Debt VS Total AssetsAXIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 9.13 indicates that AXIL is not in any danger for bankruptcy at the moment.
AXIL has a Altman-Z score of 9.13. This is amongst the best in the industry. AXIL outperforms 88.57% of its industry peers.
AXIL has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
AXIL's Debt to FCF ratio of 0.13 is amongst the best of the industry. AXIL outperforms 85.71% of its industry peers.
AXIL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
AXIL has a Debt to Equity ratio of 0.01. This is in the better half of the industry: AXIL outperforms 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 9.13
ROIC/WACC1.2
WACC8.96%
AXIL Yearly LT Debt VS Equity VS FCFAXIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

AXIL has a Current Ratio of 3.78. This indicates that AXIL is financially healthy and has no problem in meeting its short term obligations.
AXIL's Current ratio of 3.78 is amongst the best of the industry. AXIL outperforms 88.57% of its industry peers.
AXIL has a Quick Ratio of 2.66. This indicates that AXIL is financially healthy and has no problem in meeting its short term obligations.
AXIL's Quick ratio of 2.66 is amongst the best of the industry. AXIL outperforms 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.78
Quick Ratio 2.66
AXIL Yearly Current Assets VS Current LiabilitesAXIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

3

3. Growth

3.1 Past

AXIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.79%, which is quite impressive.
Looking at the last year, AXIL shows a decrease in Revenue. The Revenue has decreased by -3.17% in the last year.
AXIL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.30% yearly.
EPS 1Y (TTM)102.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.75%
Revenue 1Y (TTM)-3.17%
Revenue growth 3Y156.26%
Revenue growth 5Y94.3%
Sales Q2Q%7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AXIL Yearly Revenue VS EstimatesAXIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.64, AXIL is valued on the expensive side.
77.14% of the companies in the same industry are more expensive than AXIL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.45. AXIL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.64
Fwd PE N/A
AXIL Price Earnings VS Forward Price EarningsAXIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

AXIL's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXIL indicates a somewhat cheap valuation: AXIL is cheaper than 62.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.95
EV/EBITDA 19.73
AXIL Per share dataAXIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AXIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXIL BRANDS INC

NYSEARCA:AXIL (7/3/2025, 7:03:38 PM)

4.94

-0.06 (-1.2%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-08 2025-04-08
Earnings (Next)08-13 2025-08-13
Inst Owners12.44%
Inst Owner Change-4.7%
Ins Owners22.33%
Ins Owner Change21.84%
Market Cap32.85M
AnalystsN/A
Price TargetN/A
Short Float %0.53%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.64
Fwd PE N/A
P/S 1.22
P/FCF 30.95
P/OCF 23.51
P/B 3.4
P/tB 4.6
EV/EBITDA 19.73
EPS(TTM)0.28
EY5.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY3.23%
OCF(TTM)0.21
OCFY4.25%
SpS4.06
BVpS1.45
TBVpS1.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.15%
ROE 25.68%
ROCE 12.24%
ROIC 10.72%
ROICexc 19.33%
ROICexgc 33.66%
OM 4.76%
PM (TTM) 9.18%
GM 71.4%
FCFM 3.93%
ROA(3y)9.28%
ROA(5y)-2.18%
ROE(3y)-9.42%
ROE(5y)-29.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.09%
GM growth 5Y10.63%
F-Score4
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.1
Cap/Depr 240.07%
Cap/Sales 1.24%
Interest Coverage 267.69
Cash Conversion 98.08%
Profit Quality 42.81%
Current Ratio 3.78
Quick Ratio 2.66
Altman-Z 9.13
F-Score4
WACC8.96%
ROIC/WACC1.2
Cap/Depr(3y)63.97%
Cap/Depr(5y)86.71%
Cap/Sales(3y)0.29%
Cap/Sales(5y)0.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.17%
Revenue growth 3Y156.26%
Revenue growth 5Y94.3%
Sales Q2Q%7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.83%
OCF growth 3Y-61.79%
OCF growth 5YN/A